Curator's Take
This article matters because it showcases a fully integrated quantum‑classical workflow on a public cloud platform that can estimate molecular binding energies—a cornerstone calculation for drug discovery and materials design. By leveraging AWS Braket together with Classiq’s automated circuit synthesis and Hatch’s chemistry expertise, the proof‑of‑concept builds on recent pushes from IBM, Google and academic groups to bring quantum chemistry out of the lab and into scalable cloud services. While still limited by current hardware noise and qubit counts, the demonstration signals that end‑to‑end pipelines for real‑world chemical problems are becoming practical building blocks for future pharmaceutical pipelines.
— Mark Eatherly
Summary
Insider Brief PRESS RELEASE — Classiq and Hatch today announced the completion of a quantum-classical computational chemistry proof-of-concept (PoC), executed via Amazon Web Services (AWS) and Braket, that demonstrated a workflow for estimating molecular binding energy, a key step in understanding how small molecules interact with protein targets. Conducted through Hatch’s Dimension X open innovation challenge for the Singapore Home […]